1811 related articles for article (PubMed ID: 18205234)
21. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
[TBL] [Abstract][Full Text] [Related]
22. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
[TBL] [Abstract][Full Text] [Related]
23. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
[TBL] [Abstract][Full Text] [Related]
24. Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Starling AL; Martins-Filho OA; Lambertucci JR; Labanca L; de Souza Pereira SR; Teixeira-Carvalho A; Martins ML; Ribas JG; Carneiro-Proietti AB; Gonçalves DU
Acta Trop; 2013 Jan; 125(1):75-81. PubMed ID: 23022356
[TBL] [Abstract][Full Text] [Related]
25. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil.
Olavarria VN; Gomes Ado N; Kruschewsky Rde A; Galvão-Castro B; Grassi MF
Braz J Infect Dis; 2012; 16(4):357-60. PubMed ID: 22846124
[TBL] [Abstract][Full Text] [Related]
26. Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study.
Olindo S; Cabre P; Lézin A; Merle H; Saint-Vil M; Signate A; Bonnan M; Chalon A; Magnani L; Cesaire R; Smadja D
Arch Neurol; 2006 Nov; 63(11):1560-6. PubMed ID: 17101824
[TBL] [Abstract][Full Text] [Related]
27. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
Lenzi ME; Cuzzi-Maya T; Oliveira AL; Andrada-Serpa MJ; Araújo AQ
Clin Infect Dis; 2003 Feb; 36(4):507-13. PubMed ID: 12567310
[TBL] [Abstract][Full Text] [Related]
28. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
[TBL] [Abstract][Full Text] [Related]
29. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load.
Castro-Lima Vargens C; Grassi MF; Boa-Sorte N; Rathsam-Pinheiro RH; Olavarria VN; de Almeida Kruschewsky R; Galvão-Castro B
J Clin Virol; 2011 Nov; 52(3):177-80. PubMed ID: 21868282
[TBL] [Abstract][Full Text] [Related]
30. Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Senitzer D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
Hum Immunol; 2010 Aug; 71(8):804-8. PubMed ID: 20483367
[TBL] [Abstract][Full Text] [Related]
31. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
32. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
33. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J
Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633
[TBL] [Abstract][Full Text] [Related]
34. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
[TBL] [Abstract][Full Text] [Related]
35. Oral manifestations of human T-cell lymphotropic virus infection in adult patients from Brazil.
Martins FM; Casseb J; Penalva-de-Oliveira AC; de Paiva MF; Watanuki F; Ortega KL
Oral Dis; 2010 Mar; 16(2):167-71. PubMed ID: 20374504
[TBL] [Abstract][Full Text] [Related]
36. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
[TBL] [Abstract][Full Text] [Related]
38. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
Ramirez E; Cartier L; Torres M; Barria M
J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
[TBL] [Abstract][Full Text] [Related]
39. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
[TBL] [Abstract][Full Text] [Related]
40. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
